Recombinant bacteria as vaccine carriers of heterologous antigens

Concepts in Vaccine Development

Volumn , Issue , 2012, Pages 327-360

  Hormaeche, Carlos E ^a   Anjam Khan, C M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85064854391     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (170)

1. Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M., and Sadoff, J. (1990) Oral Salmonella: malaria recombinants induce specific cytotoxic CD8+ cytotoxic T cells. J Exp Med 172, 1083-1090
2. Agteberg, M., Adriaanse, H., Lankhof, H., Meloen, R., and Tommassen, J. (1990) Outer membrane protein PhoE protein of Escherichia coli as a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus. Vaccine 8, 85-91
3. Aldovini, A. and Young, R. A. (1991) Humoral and cell mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351,479-482
4. Attridge, S. (1991) Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to preimmunization antibody levels. Vaccine 9, 877-882
5. Attridge, S. R., Daniels, D., Morona, J. K., and Morona, R. (1990) Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty2la clone EX210. Microb Pathogen 8, 177-188
6. Attridge, S., Hackett, J., Morona, R., and Whyte, P. (1988) Towards a live oral vaccine against enterotoxigenic Escherichia coli. Vaccine 6, 387-390
7. Bao, J. X. and Clements, J. D. (1991) Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infect Immun 59, 3841-3845
8. Baron, L. S., Kopecko, D. J., Formal, S. J., Seid, R., Guerry, P., and Powell, C. (1987) Introduction of Shigella flexneri 2a type and group antigens genes into oral typhoid vaccine strain Salmonella typhi Ty21a. Infect Immun 55, 2797-2801
9. Black, R. E., Levine, M. M., Clements, M. L., Losonsky, G., Herrington, D., Berman, S., and Formai, S. B. (1987) Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis 155, 1260-1265
10. Bloom, B. R. and Fine, P. E. M. (1994) The BCG experience: implications for future vaccines against tuberculosis. In: Tuberculosis: pathogenesis, prevention and control. Bloom, B. R (ed.), American Society for Microbiology, Washington, 531-557
11. Bowen, J. C., Alpar, O., Philpotts, O., Roberts, I. S., and Brown, M. R. W. (1990) Preliminary studies on infection by attenuated salmonella in guinea pigs and on expression of herpes simplex virus. Res Microbiol 141, 873-877
12. Broekhuysen, M. P., van Rijn, J. M. M., Blom, A. J. M., Pouwels, P. H., Enger-Valk, B. E., Brown, F., and Francis, M. (1987) Fusions proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease protect both the natural host and laboratory animals. J Gen Virol 68, 3137-3143
13. Brown, A. and Hormaeche, C. E. (1989) The immune response to salmonellae in mice and humans studied by immunoblots and ELISA. Microb Pathogen 6, 445-454
14. Brown, A., Hormaeche, C. E., Demarco de Hormaeche, R. A., Dougan, G., Winther, M., Maskell, D., and Stocker, B. A. D. (1987) An attenuated aro A S.typhimurium vaccine elicits humoral and cellular immunity to cloned beta galactosidase in mice. J Infect Dis 155, 86-92
15. Buchmeier, N. A. and Heffron, F. (1990) Induction of salmonella stress proteins upon infection of macrophages. Science 248, 730-732
16. Cao, Y., Wen, Z., and Lu, D. (1992) Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium. Infect Immun 60, 2823-2827
17. Cárdenas, L., Dasgupta, U., and Clements, J. D. (1994) Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 12,833-840
18. Carrier, M. J., Chatfield, S. N., Dougan, G., Nowicka, U. T., O'Callaghan, D., Beesley, J. E., Milano, S., Ciliari, E., and Liew, F. Y. (1992) Expression of human IL-1 beta in Salmonella typhimurium: A model system for the delivery of recombinant therapeutic proteins in vivo. J. Immunol. 148, 1176-1181
19. Chabalgoity, J. A., Khan, C. M. A., Nash, A. A., and Hormaeche, C. E. (1996) A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol Microbiol 19, 791-801
20. Chabalgoity, J. A., Villarreal-Ramos, B., Khan, C. M. A., Chatfield, S. N., Demarco de Hormaeche, R. A., and Hormaeche, C. E. (1995) Influence of preimmunisation with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier. Infect Immun 63, 2564-2569
21. Charbit, A., Martineau, P., Ronco, J., Ledere, C., Lo-Man, R., Michel, V., O'Callaghan, D., and Hofnung, M. (1993) Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aro A strain of Salmonella typhimurium upon genetic coupling to Escherichia coli carrier proteins. Vaccine 12, 1221-1228
22. Chatfield, S. N., Charles, I. G., Makoff, A. J., Oxer, M. D., Dougan, G., Pickard, D., Slater, D., and Fairweather, N. F. (1992) Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. BioTechnology 10, 888-892
23. Chatfield, S. N., Fairweather, N. F., Charles, I., Pickard, D., Levine, M., Hone, D., Posada, M., Strugnell, R. A., and Dougan, G. (1992) Construction of a genetically defined Salmonella typhi Ty2 aro A, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Infect Immun 70,53-60
24. Chatfield, S. N., Roberts, M., Dougan, G., Hormaeche, C., and Khan, C. M. A. (1995) The development of oral vaccines against parasitic diseases utilising live attenuated Salmonella. Parasitology 10, S17-S24
25. Chatfield, S. N., Strahan, K., Pickard, D., Charles, I. G., Hormaeche, C. E., and Dougan, G. (1991c) Evaluation of Salmonella typhimurium strains harboring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathogen 12, 145-151
26. Cieslak, P. R, Tonghai, Z., and Stanley, Jr. S. L. (1993) Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain. Vaccine 11, 773-776
27. Clark-Curtiss, J. E., Thole, J. E. R., Sathish, M., Bosecker, B. A., Sela, S., de Carvalho, E. F., and Esser, R. E. (1990) Protein antigens of Mycobacterium leprae. Res Microbiol 141, 859-871
28. Clements, J. D. and Cárdenas, L. (1990) Vaccines against enterotoxigenic bacterial pathogens based on hybrid Salmonella that express heterologous antigens. Res Microbiol 747,981-993
29. Clements, J. D., Lyon, F. L., Lowe, K. L., Farrand, A. L., and El-Morshidy, S. (1988) Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat labile enterotoxin of Escherichia coli. Infect Immun 53, 685-692
30. Cohen, S., Powell, C. J., Dubois, D. R., Hartman, A., Summers, P. L., and Eckels, K. H. (1990) Expression of the envelope antigen of dengue virus in vaccine strains of Salmonella. Res Microbiol 141, 855-858
31. Cooper, G. A., Nicholas, R. A. J., Cullen, G. A., and Hormaeche, C. E. (1990) Vaccination of chickens with an S.enteritidis aroA live oral salmonella vaccine. Microb Pathogen 9, 255-265
32. Cooper, G. L., Venables, L. M., Nicholas, R. A. J., Cullen, G. A., and Hormaeche, C. E. (1992) Vaccination of chickens with chicken-derived Salmonella enteritidis phage type 4 live oral salmonella vaccines. Vaccine 10, 247-254
33. Cooper, G. L., Venables, L. M., Nicholas, R. A. J., Cullen, G. A., and Hormaeche, C. E. (1993) Further studies of the application of liver Salmonella enteritidis aroA vaccines in chickens. Vet Record 133, 31-36
34. Cooper, G. L., Venables, L. M., Woodward, M. J., and Hormaeche, C. E. (1994) The invasiveness and persistence of S. enteritidis, S. typhimurium and a genetically-defined S. enteritidis aroA strain in young chickens. Infect Immun 62,4739-4746
35. Cooper, G. L., Venables, L. M., Woodward, M. J., and Hormaeche, C. E. (1994) Vaccination of chickens with CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine. Infect Immun 62, 4747-4754
36. Coulson, N. M., Fulop, M., and Titball, R. W. (1994) Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge. Vaccine 12, 1395-1401
37. Curtiss III, R., Goldschmidt, R. M., Fletchall, N. B., and Kelly, S. M. (1988) Avirulent Salmonella typhimurium Dcya Dcrp oral vaccine strains expressing a streptococcal colonization and virulence antigen. Vaccine 6, 155-160
38. Curtiss III, R., Kelly, S. M., Gulig, P. A., and Nakayama, K. (1989) Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol 146, 35-49
39. Curtiss, R. I. (1986) Genetic analysis of Streptococcus mutans virulence and prospects for an anticaries vaccine. J Dent Res 65, 1034-1045
40. Dearlove, C. E., Forrest, B. D., van den Bosch, L., and LaBrooy, J. T. (1992) The antibody response to an oral Ty2la-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a (letter). J Infect Dis 165, 182-183
41. Denich, K., Börlin, P., O'Hanley, P., Howard, M., and Heath, A. W. (1993) Expression of the mouse interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium·. persistence and immune response in B ALB/c mice and susceptibility to macrophage killing. Infect Immun 67,4818-4827
42. DiJohn, D., Wassermann, S. S., Torres, J. R., Cortesía, M. J., Murillo, J., Losonsky, G. A., Herrington, D. A., Stürcher, D., Levine, M. M. (1989) Effect of priming with carrier on response to conjugate vaccine. Lancet 1415-1418
43. Dougan, G., Seilwood, R., Maskell, D., Sweeney, K., Beesley, J., Hormaeche, C. E. (1986) In vivo properties of a cloned K88 adherence antigen determinant. Infect Immun 52, 344-347
44. Dunne, M., Al-Ramadi, B. K., Barthold, S. W., Flavell, R. A., and Fikrig, E. (1995) Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevent murine Lyme borreliosis. Infect Immun. 63, 1611-1614
45. Dusek, D. M., Progulske-Fox, A., Whitlock, J., and Brown, T. A. (1993) Isolation and characterisation of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium. Infect Immun 61, 940-946
46. Ervin, S. E., Small, P. A. Jr., and Gulig, P. A. (1993) Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice. Microb Pathogen 15, 93-101
47. Everest, P., Frankel, G., Li, J., Lund, P., Chatfield, S., and Dougan, G. (1995) Expression of lacZ from the htrA, nirB and groE promoters in a salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol Letts 125, 97-101
48. Fairweather, N. F., Chatfield, S. N., Makoff, A., Strugnell, R., Bester, J., Maskell, D. J., and Dougan, G. (1990) Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect Immun 58, 1323-1326
49. Fayolle, C., O'Callaghan, D., Martineau, P., Charbit, A., Clément, J. M., Hofnung, M., and Leclerc, C. (1994) Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium. Infect Immun 62, 4310-4319
50. Flynn, J. L., Weiss, W. R., Norris, K. A., Seifert, H. S., Kumar, S., and So, M. (1990) Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen delivery system. Mol Microbiol 4,2111-2118
51. Formal, S. B., Baron, L. S., Kopecko, D. J., Washington, O., Powell, C., and Life, C. A. (1981) Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 34, 746-750
52. Forrest, B. D., LaBrooy, J. T., Robinson, P., Dearlove, C. E., and Shearman, D. J. (1991) Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun 59, 1206-1209
53. Fouts, T. R., Lewis, G. K., and Hone, D. M. (1995) Construction and characterisation of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine. Vaccine 13, 561-569
54. Franchini, G., Robert-Guroff, M., Tartaglia, J., Aggarwal, A., Abimiku, A., Benson, J., Markham, P., Limbach, K., Hurteau, G., Fullen, J., Aldrick, K., Miller, N., Sadoff, J., Paoletti, E., and Gallo, R. C. (1995) Highly attenuated HIV type 2 recombinant poxviruses, but mot HIV-2 recombinant Salmonella vacines, induce long-lasting protection in rhesus macaques. AIDS Research and Human Retroviruses, 8, 909-920
55. Gao, X.-M., Tite, J., Lipscombe, M., Rowland-Jones, S., Ferguson, D. J. P., and McMichael, A. J. (1992) Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific T-lymphocytes. Infect Immun 60,3780-3789
56. Gentschev, I., Sokolovic, Z., Kohler, S., Krahne, G. F., Hof, H., Wagner, J., and Goebel, W. (1992) Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system. Infect. Immun. 60, 5091-5098
57. Girón, J. A., Xu, J.-G., González, C. R., Hone, D., Kaper, J. B., and Levine, M. M. (1995) Simultaneous expression of CFA/I and CS3 colonisation factor antigens of enterotoxigenic Escherichia coli by DaroC, DaroD Salmonella typhi vaccine strain CVD 908. Vaccine 13, 939-946
58. González, C., Hone, D., Noriega, F. R., Tacket, C. O., Davis, J. R., Losonsky, G., Nataro, J. P., Hoffman, S., Malik, A., Nardin, E., Sztein, M. B., Heppner, G., Fouts, T. R., Isibasi, A., and Levine, M. M. (1994) Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum·, strain construction and safety and immunogenicity in humans. J Infect Dis 169, 927-931
59. Gottstein, B., Muller, N., Cryz, S. J. J., Vogel, M., Tanner, I., and Seebeck, T. (1990) Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain. Paras Immunol 12, 163-174
60. Grosjean, J. and Friers, W. (1982) Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene 18, 199-209
61. Guzmán, C. A., Brownlie, R. M., Kadurugamuwa, J., Walker, M. J., and Timmis, K. N. (1991) Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis. Infect Immun 59, 4391-4397
62. Hartman, A. B., Ruiz, M. M., and Shultz, C. L. (1991) Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain. J Clin Microbiol 29, 27-32
63. Herrington, D. A., van de Verg, L., Formai, S. B., Haie, T. L., Tall, B. D., Crysz, S. J., Tramont, E. C., and Levine, M. M. (1990) Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 8, 353-357
64. Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, Ch. H., Goebel, W., and Kaufmann, S. H. E. (1996) Superior efficacy of secreted over somatic antigen display in vaccine induced protection against an intracellular bacterial pathogen. Proc. Natl. Acad. Sci. USA 93, 1458-1463
65. Hess, J., Gentschev, I., Szalay, G., Ladel, C., Bubert, A., Goebel, W., and Kaufmann, S. H. E. (1995) Listeria monocytogenes P60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium. Infect. Immun. 63, 2047-2053
66. Hohmann, E. L., Oletta, C. A., Loomis, W. P., and Miller, S. I. (1995) Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc Natl Acad Sci USA 92, 2904-2908
67. Hone, D. M., Attridge, S. R., Forrest, B., Morona, R., Daniels, D., LaBrooy, J. T., Bartholomeusz, R. C. A., Shearman, D. J. C., and Hackett, J. (1988) A galEçVi antigen negative) mutant of Salmonella typhimurium Ty2 retains virulence in humans.Infect. Immun. 56, 1326-1333
68. Hone, D., Attridge, S., van den Bosch, L., and Hackett, J. (1988) A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb Pathogen 5, 407-418
69. Hopkins, S., Kraehenbul, J.-P., Schödel, F., Potts, A., Peterson, D., de Grandi, P., and Nardelli-Haefliger, D. (1995) A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 63, 3279-3286
70. Hormaeche, C. E., Khan, C. M. A., Mastroeni, P., Villarreal, B., Dougan, G., Roberts, M., and Chatfield, S. N. (1994) (1995) Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In Ala'Aldeen, D. and Hormaeche, C. E. (eds) Molecular and Clinical Aspects of Vaccine Development. Chichester, John Wiley, 119-153
71. Hormaeche, C. E., Villarreal, B., Mastroeni, P., Dougan, G., and Chatfield, S. N. (1993) Immunity mechanisms in experimental salmonellosis. In: Biology of Salmonella, Cabello, F., Hormaeche, C. E., Mastroeni, P., and Bonina, L. (eds.) New York, Plenum Press, 223-235
72. Hsu, H. S. (1993) Is Salmonella an intracellular pathogen? In: Biology of Salmonella, Cabello, F., Hormaeche, C. E., Mastroeni, P., Bonina, L. (eds.) New York, Plenum Press, 121-129
73. Ianaro, A., Xu, D., O'Donnell, M., Di Rosa, M., and Liew, F. Y. (1995) Expression of TGF-b in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-g, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 84, 8-15
74. Jagusztyn-Krynicka, E. K., Clark-Curtiss, J., and Curtiss III, R. (1993) Escherichia coli heatlabile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect Immun 61, 1004-1015
75. Johnson, K. S., Charles, I. G., Dougan, G., Miller, I. A., Pickard, D., O'Goara, P., Costa, G., Ali, T., and Hormaeche, C. E. (1991) The role of a stress-response protein in bacterial virulence. Mol Microbiol 5, 401-407
76. Jones, P. W., Dougan, G., Hayward, C., Mackensie, N., Collins, P., and Chatfield, S. N. (1991) Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 9, 29-34
77. Kameoka, M., Nishino, Y., Matsuo, K., Ohara, N., Kimura, T., Yamazaki, A., Yamada, T., and Ikuta, K. (1994) Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12, 153-158
78. Katz, J., Michalek, S. M., Curtiss, R. I., Harmon, C., Richardson, G., and Mestecky, J. (1987) Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses. Adv Exp Med Biol 216B, 1741-1747
79. Keitel, W. A., Bond, N. L., Zahradnik, J. M., Cramton, T. A., and Robbins, J. B. (1994) Clinical and serologic responses following primary and booster immunisation with Salmonella typhi Vi capsular polysacharide vaccines. Vaccine 12, 195-199
80. Khan, C. M. A., Villarreal-Ramos, B., Pierce, R. J., Riveau, G., Demarco de Hormaeche, R., McNeill, H., Ali, T., Chatfield, S., Capron, A., Dougan, G., and Hormaeche, C. E. (1994) The construction, expression and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci USA 91, 11261-11265
81. Khan, C. M. A., Villarreal-Ramos, B., Pierce, R. J., Riveau, G., Demarco de Hormaeche, R., McNeill, H., Ali, T., Chatfield, S., Capron, A., Dougan, G., and Hormaeche, C. E. (1994) The construction, expression and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide comprising amino acids 115-121 of the P28 glutathione S-transferase, expressed as C-terminal fusions to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. J Immunol 153, 5634-5642
82. Klemm, P. and Hedegaard, L. (1990) Fimbriae of Escherichia coli as carriers of heterologous antigenic sequences. Res Microbiol 141, 1013-1017
83. Lagranderie, M., Murray, A., Gicquel, B., Ledere, C., and Gheorghiu, M. (1993) Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 11, 1283-1290
84. Langermann, S., Palaszynski, S. R., Burlein, J. E., Koenig, S., Hanson, M. S., Briles, D. E., and Stover, C. K. (1994) Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J Exp Med 180, 2277-2286
85. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., and Koenig, S. (1994) Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552-555
86. Ledere, C., Charbit, A., Molla, A., and Hofnung, M. (1989) Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization. Vaccine 7, 242-248
87. Lipscombe, M., Charles, I. G., Roberts, M., Dougan, G., Tite, J., and Fairweather, N. (1991) Intranasal immunisation using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen. Mol Microbiol 5, 1385-1392
88. Maskell, D. J., Sweeney, K. J., O'Callaghan, D., Hormaeche, C. E., Liew, F. Y., and Dougan, G. (1987) Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heatlabile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathogen 2, 211-221
89. Matsumoto, S., Matsuo, T., Ohara, N., Hotokezaka, H., Naito, M., Minami, J., and Yamada, T. (1995) Cloning and sequencing of a unique antigen MPT70 from Mycobacterium tuberculosis H37Rv and expression in BCG using E. coi-mycobacteria shuttle vector. Scand J Immunol 41, 281-287
90. Miller, C. G. (1987) Protein degradation and protelolytic modification. In Niedhardt, F. C., Ingraham, J. L., Low, K. B., Magasinik, B., Schaechter, M., and Umbarger, H. E. (eds.) Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, American Society for Microbiology, 680-691
91. Molina, N. C. and Parker, C. D. (1990) Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous haemagglutinin antigen from Bordetella pertussis. Infect Immun 58, 2523-2528
92. Morin, J. E., Lübeck, M. D., Mason, B. B., Molnar-Kimber, K. L., Dheer, S. K., Bhat, B. M., Chanda, P. K., Natuk, R. J., Chengalvala, M. V. R., Mizutani, S., Davis, A. R., and Hung, P. P. (1990) Recombinant adenovirus vaccines for hepatitis B virus. In: New generation vaccines, Woodrow, J. C., Levine, M. M. (eds.), Marcel Dekker, New York, 448-457
93. Morona, R., Morona, J. K., Considine, A., Hackett, J. A., van den Bosch, L., Beyer, L., and Attridge, S. R. (1994) Construction of K88-and K99-expressing clones of Salmonella ty phimurium G30: immunogenicity following oral administration to pigs. Vaccine 12, 513-517
94. Mukkur, T. K. S., McDowell, G. H., Stocker, B. A. D, and Lascelles, A. K. (1987) Protection in salmonellosis in mice and sheep by immunization with aromatic dependent Salmonella typhimurium. J Med Microbiol 24, 11-19
95. Murray, A., Winter, N., Lagranderie, M., Hill, D. F., Rauzier, J., Timm, J., Leclerc, C, Moriarty, K. M., Gheorghiu, M., and Gicquel, B. (1992) Expression of Escherichia coli betagalactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses. Mol. Microbiol. 22, 3331-3342
96. Nakayama, K., Kelly, S. M., and Curtiss III, R. (1988) Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a salmonella vaccine strain. Bio/Technology 6, 693-697
97. Newton, S. M. C., Jacob, C. O., and Stocker, B. A. D. (1989) Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244, 70-72
98. Newton, S. M. C., Joys, T. M., Anderson, S. A., Kennedy, R. C., Hovi, M. E., and Stocker, B. A. D. (1995) Expression and immunogenicity of an 18-residue epitope of HIV gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol 146, 203-216
99. Newton, S. M. C., Klebba, P. E., Hofnung, M., and Charbit, A. (1995) Studies of the anaerobically inducible promoter BnirB and the improved expression of bacterial antigens. Res Microbiol 146, 193-202
100. O'Callaghan, D., Charbit, A., Martineau, P., Leclerc, C., van der Werf, S., Nauciel, C., and Hofnung, M. (1990) Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins. Res Microbiol 141, 963-969
101. O'Callaghan, D., Maskell, D. J., Beesley, J. E., Lifely, M. R., Roberts, M., Boulnois, G., and Dougan, G. (1988) Characterisation and in vivo behaviour of a Salmonella typhimurium aro A. strain expressing Escherichia coli Kl polysaccharide. FEMS Microbiol Letts 52, 269-274
102. O'Donnell, M. A., Aldovini, A., Duda, R. B., Yang, H., Szilvasi, A., Young, R. A., and De Wolf, W. C. (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62, 2508-2514
103. O'Gaora, P., Roberts, M., Bowe, F., Hormaeche, C. E., Demarco de Hormaeche, R. A., Cafferkey, M., Tite, J., and Dougan, G. (1990) Yersinia enterocolitica aroA mutants as carriers of the B subunit of the Escherichia coli heat-labile enterotoxin to the murine immune system. Microb Pathogen, 9, 105-116
104. Oxer, M. D., Bentley, C. M., Doyle, J. G., Peakman, T. C., Charles, I. G., and Makoff, A. J. (1991) High level heterologous expression in E. coli using the anaerobically activated nirB promoter. Nucl Acids Res 19, 2889-2892
105. Oyston, P. C. F., Williamson, E. D., Leary, S. E. C., Eley, S. M., Griffin, K. F., and Titball, R. W. (1995) Immunisation with live recombinant Salmonella typhimurium aroA producing Fl antigen protects against plague. Infect Immun 63, 563-568
106. Pan, Z. K., Ikonomidis, G., Lazenby, A., Pardoll, D., and Paterson, Y. (1995) A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour challenge and causes regression of established tumours. Nature Medicine 1, 471-480
107. Pastoret, P. P., Boulanger, D., and Brochier, B. (1995) Field trials of a recombinant rabies vaccines. Parasitology, 110, S37-S42
108. Paton, J. C, Morona, J. K, Harrer, S., Hansman, D., and Morona, R. (1993) Immunisation of mice with Salmonella typhimurium aroA expressing a genetically toxoided derivative of the pneumococcal toxin pneumolysin. Microb Pathogen 14, 95-102
109. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J, and Harding, C. (1993) Phagocytic processing of bacterial antigens for presentation to T cells. Nature 361, 359-362
110. Poirier, T. P., Kehoe, M. A., and Beachey, E. H. (1988) Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med 168, 25-32
111. Redman, T. K., Harmon, C. C., Lallone, R., and Michalek, S. M. (1995) Oral immunisation with recombinant Salmonela typhimurium expressing surface protein antigen A of Streptococcu sobrinus: dose response and induction of protective humoral responses in rats. Infect Immun 65,2004-2011
112. Reeves, P. R., Johnson, M. A., Holmes, J. H., and Dyall-Smith, M. L. (1991) Expression of rotavirus VP7 antigens in fusions with bacterial proteins. Res Microbiol 141, 1019-1025
113. Roberts, M., Chatfield, S. N., and Dougan, G. (1994) Salmonella as carriers of heterologous antigens. In O'Hagan, D. T. (ed.) Novel delivery systems for oral vaccines. London, CRC Press, 27-58
114. Robertsson, J. A., Lindberg, A. A., Hoiseth, S., and Stocker, B. A. D. (1983) Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunisation with live or inactivated vaccines. Infect Immun 41, 742-757
115. Sadoff, J. C., Balloul, W. R., Baron, L. S., Majarían, W. R., Brey, R. N., Hockmeyer, W. T., Young, J., Crysz, J. J., Ou, J., Lowell, G. J., and Chulay, J. D. (1988) Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240, 336-338
116. Salas, V. E., Plebanski, M., Castro, S., Perales, G., Mata, E., López, S., Arias, C. F. (1990) Synthesis of the surface glycoprotein of rotavirus SALI in the aro A strain of Salmonella typhimurium SL3261. Res Microbiol 141, 883-886
117. Schäfer, R., Portnoy, D. R., Brasseil, S. A., and Paterson, Y. (1992) Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 149, 53-59
118. Schodel, F. (1992) Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. Adv Virus Res 41,409-460
119. Schodel, F. and Will, H. (1990) Expression of hepatitis B virus antigens in attenuated salmonellae for oral immunisation. Res Microbiol 141, 831-837
120. Schodel, F., Milich, D. R., and Will, H. (1990) Hepatitis B virus nucleocapsid / pre-S2 fusion proteins expressed in attenuated salmonellae for oral vaccination. J Immunol 145, 4317-4321
121. Schödel, F., Will, H., and Milich, D. R. (1991) Hybrid hepatitis-B virus core/pre-S particles expressed in live attenuated salmonellae for oral immunization In: Vaccines 91: modern approaches to new vaccines including prevention of AIDS. Chanock, R. M., Ginsberg, H. S., Brown, F., and Lerner, A. (eds), New York: Cold Spring Harbor Laboratory Press, 319-325
122. Schorr, J., Knapp, B., Hundt, E., Küpper, H. A., and Amann, E. (1991) Surface expression of malaria antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. Vaccine 9, 675-681
123. Schütze, M.-P., Leclerc, C., Jolivet, M., Audibert, F., and Chedid, L. (1985) Carrier-induced suppression, a major issue for future synthetic vaccines. J Immunol 135, 1354-1423
124. Segali, T. and Lindberg, A. A. (1991) Salmonella dublin experimetal infection in calves: protection after oral immunisation with an auxotrophic aroA live vaccine. J Vet Med 38, 142-160
125. Seid, R. C. J., Kopecko, D. J., Sadoff, J. C., Schneider, H., Baron, L. S., and Formal, S. B. (1984) Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. J Biol Chem 259, 9028-9034
126. Shen, H., Slifka, M. K., Matloubian, M., Jensen, E. R., Ahmed, R., and Miller, J. F. (1995) Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci USA 92, 3987-3991
127. Simonet, M., Fortineau, N., Beretti, J. L., and Berche, P. (1994) Immunisation with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosis. Infect Immun 62, 863-867
128. Sjösted, A., Sandström, G., and Tärnvik, A. (1990) Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis: a model for identification of bacterial determinants relevant to the host defence against tularemia. Res Microbiol 141, 887-891
129. Sjöstedt, A., Sandström G., and Tärnvik, A. (1992) Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun 60, 2855-2862
130. Smith, B. P., Reina-Guerra, M., Hoiseth, S. K., Stocker, B. A. D., Habasha, F., Johnson, E., and Merritt, F. (1984) Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am J Vet Res 45, 59-66
131. Smith, B. P., Reina-Guerra, M., Stocker, B. A. D., Hoiseth, S. A., and Johnson, E. (1984) Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am J Vet Res 45, 2231-2235
132. Sory, M.-P. and Cornells, G. R. (1990) Delivery of cholera toxin B subunit by using a recombinant Yersinia enterocolitica strain as a live oral vector. Res Microbiol, 141,921-931
133. Stabel, T. J., Mayfield, J. E., Morfitt, D. C., and Wannemuehler, M. J. (1993) Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [cya-12 (crp-cdt) 19] mutant containing a recombinant plasmid. Infect Immun 61, 610-618
134. Stabel, T. J., Mayfield, J. E., Tabatabai, L. B, and Wannemuehler, M. J. (1991) Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31 kilodalton protein of Brucella abortus. Infect Immun. 59,2941-2947
135. Stabel, T. J., Mayfield, J. E., Tabatabai, L. B., and Wannemuehler, M. J. (1990) Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect Immun 58, 2048-2055
136. Stevenson, G. and Manning, P. (1985) Galactose epimeraseless (galE) mutant G30 of Salmonella typhimurium is a good potential live oral vaccine carrier for fimbrial antigens. FEMS Microbiology Letters 28, 317-321
137. Stocker, B. A. D. (1990) Aromatic-dependent Salmonella as live vaccine presenters of foreign inserts in flagellin. Res Microbiol 141, 787-796
138. Stocker, B. A. D. and Newton, S. M. (1994) Immune responses to epitopes inserted in salmonella flagellin. Intern Rev Immunol 11, 167-178
139. Stover, C. K. (1994) Recombinant vaccine delivery systems and encoded vaccines. Curr Opin Immunol 6, 568-571
140. Stover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., and Barbour, A. G. (1993) Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine. J Exp Med 178, 197-209
141. Stover, C. K., De la Cruz, V. F., Bansal, G. P., Hanson, M. S., Fuerst, T. R., Jacobs, W. R. Jr., and Bloom, B. R. (1992) Use of recombinant BCG as a vaccine delivery vehicle. Adv Exp Med Biol 327, 175-182
142. Strahan, K. M., Kitchin, P., and Hormaeche, C. E. (1992) SN-Salmonella constructs and their potential as vaccine candidates. Vaccine Res 1, 257-263
143. Strahan, K., Chatfield, S. N., Tite, J., Dougan, G., and Hormaeche, C. E. (1992) Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines. Microb Pathogen 72,311-317
144. Strugnell, R. A., Maskell, D., Fairweather, N. F., Pickard, D., Cockayne, A., Penn, C., and Dougan, G. (1990) Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88, 57-63
145. Strugnell, R., Dougan, G., Chatfield, S., Charles, I., Fairweather, N., Tite, J., Li, J. L., Beesley, J., and Roberts, M. (1992) Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun 60, 3994-4002
146. Strugnell, R., Schouls, L., Cockayne, A., Bailey, M., van Embden, J., and Penn, C. (1989) Experimental syphilis vaccines: use of aro A Salmonella typhimurium to deliver recombinant Treponema pallidum antigens. In: Meheus, A. and Spier, R. E. (eds.), Vaccines for Sexually Transmitted Diseases. Oxford, Butterworths, 107-113
147. Su, G. F., Brahmbhatt, H. N., Wehland, J., Rohde, M., and Timmis, K. N. (1992) Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aro A strains and stimulation of B subunit-specific mucosal and serum antibody responses. Infect Immun 60, 3345-3359
148. Tacket, C. O. and Levine, M. M. (1994) Typhoid vaccines-old and new. In Ala'Aldeen, D. and Hormaeche, C. E. (eds) Molecular and Clinical Aspects of Vaccine Development. Chichester: John Wiley, 156-178
149. Tacket, C. O., Forrest, B., Morona, R., Attridge, S. R., LaBrooy, J., Tall, B. D., Reymann, M., Rowley, D., and Levine, M. M. (1990) Safety, immunogenicity and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun 58, 1620-1627
150. Tarkka, E., Muotiala, A., Karvonen, M., Saukkonen-Laitinen, K., and Sarvas, M. (1989) Antibody production to a meningococcal outer membrane protein cloned into a live Salmonella typhimurium aroA vaccine strain. Microb Pathogen 6, 327-335
151. Tijhaar, E. J., Zheng-Xin, Y., Karlas, J. A., Meyer, T. F., Stukart, M., Osterhaus, A. D. M. E., and Mooi, F. R. (1994) Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 12, 1004-1011
152. Tite, J. P., Gao, X.-M., Hughes-Jenkins, C. M., Lipscombe, M., O'Callaghan, D., Dougan, G., and Liew, F.-Y. (1990) Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology 70, 540-546
153. Tramont, E. C., Chung, R., Berman, S., Keren, D., Kapfer, C., and Formal, S. B. (1984) Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-IC). J Infect Dis 149, 133-136
154. Turner, S. J., Carbone, F. R., and Strugnell, R. A. (1993) Salmonella typhimurium AaroA AaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T-lymphocytes in mice. Infect Immun 61, 5374-5380
155. Van de Verg, L., Herrington, D. A., Murphy, J. R., Wasserman, S. S., Formal, S. B., and Levine, M. M. (1990) Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S.sonnei. Infect Immun 58, 2002-2004
156. Verma, N. K., Zeigler, H. K., Stocker, B. A. D., and Schoolnik, G. K. (1995) Induction of a cellular immune response to a defined T cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 13, 235-244
157. Verma, N. K., Zeigler, H. K., Wilson, M., Khan, M., Safley, S., Stocker, B. A. D., and Schoolnikm G. K. (1995) Delivery of a class I and class II MHC restricted T cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 13, 142-150
158. Vidal, S. M., Malo, D., Vogan, K., Skamene, E., and Gros, P. (1993) Natural resistance to infection by intracellular parasites: isolation of a candidate for Beg. Cell 73, 469-485
159. Vrtala, S., Grote, M., Ferreira, F., Susani, M., Stocker, B., Kraft, D., and Valenta, R. (1995) Humoral immune response to recombinant tree pollen allergens (Bet V I and Bet V IT) in mice: construction of a live oral allergy vaccine. Int Arc Allergy Immunol 107, 290-294
160. Walker, M. J., Rohde, M., Timmis, K. N., and Guzman, C. A. (1992) Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aro A, Salmonella typhi Tγ21α, and invasive Escherichia coli expressing recombinant pertussis toxin SI subunit. Infect Immun 60, 4260-4268
161. Wells, J. M., Wilson, P. W., Norton, P. M., Casson, M. J., and Le Page, R. W. F. (1993) Lactococcus lactis: high level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8, 1155-1162
162. Wick, M. J., Harding, C. V., Twesten, N. J., Normark, S. J., and Pfeifer, J. D. (1995) ThephoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol Microbiol 16, 465-476
163. Winter, N., Lagranderie, M., Gangloff, S., Leclerc, C., Gheorghiu, M., and Gicquel, B. (1995) Recombinant BCG strains expressing the SIV(mac251)nef gene induces proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13, 471-478
164. Winter, N., Lagranderie, M., Rauzier, J., Timm, J., Leclerc, C., Guy, B. et al. (1991) Expression of heterologous genes in Mycobacterium tuberculosis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 109, 47-54
165. Wolowczuk, I., Auriault, C., Bossus, M., Boulanger, D., Gras-Masse, H., Mazingue, C., Pierce, R. J., Grezel, D., Reid, G. D., Tartar, A., and Capron, M. (1991) Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma monsoni SM28 GST antigen in rat, mouse and monkey: 1: partial protection of Fischer rats after active immunisation. J Immunol 146, 1987-1995
166. Woodrow, G. C. and Levine, M. M. (eds.) (1990) New generation vaccines. Marcel Dekker, New York
167. Wu, J. Y., Newton, S. M. C., Judd, A., Stocker, B. A. D., and Robinson, W. S. (1989) Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proc Natl Acad Sci USA 86, 4726-4730
168. Xu, D., McSorley, S. J., Chatfield, S. N., Dougan, G., and Liew, F. Y. (1995) Protection against Leishmania major infection in genetically susceptible BALB/c mice by GP63 delivered orally in attenuated Salmonella typhimurium (AroA-AroD') Immunology 85, 1-7
169. Yang, D. M., Fairweather, N., Button, L. L., McMaster, W. R., Kahl, L. P., and Liew, F. Y. (1990) Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145, 2281-2285
170. Yasutomi, Y., Koenig, S., Haun, S. S., Stover, C. K., Jackson, R. K., Conard, P., Conley, A. J., Emini, E. A., Fuerst, T. R., and Letvin, N. L. (1993) Immunization with recombinant BCGSIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 150, 3101-3107